Shenzhen Kangzhe Pharmaceutical Co., Ltd. Report issue

For profit Phase 3
Founded: Shenzhen China (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2007
NCT00644020
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Shenzhen Kangzhe Pharmaceutical Co., Ltd.